Biogen Inc. (BIIB) said, for full year 2022, the company now projects non-GAAP EPS of $16.50 to $17.15, updated from prior guidance range of $15.25 to $16.75. Total revenue is now expected in a range of $10.0 to $10.15 billion, revised from prior guidance range of $9.9 to $10.1 billion. The company said the increase in full year 2022 revenue and non-GAAP EPS guidance is driven primarily by better than-expected topline performance and continued cost management.
from RTT - Earnings https://ift.tt/rHfj4Ka
via IFTTT
No comments:
Post a Comment